AU2013344571A1 - Gonorrheal MtrE peptides and vaccines - Google Patents

Gonorrheal MtrE peptides and vaccines Download PDF

Info

Publication number
AU2013344571A1
AU2013344571A1 AU2013344571A AU2013344571A AU2013344571A1 AU 2013344571 A1 AU2013344571 A1 AU 2013344571A1 AU 2013344571 A AU2013344571 A AU 2013344571A AU 2013344571 A AU2013344571 A AU 2013344571A AU 2013344571 A1 AU2013344571 A1 AU 2013344571A1
Authority
AU
Australia
Prior art keywords
mtre
amino acid
seq
protein
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013344571A
Other languages
English (en)
Inventor
Amanda DEROCCO
Ann JERSE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Publication of AU2013344571A1 publication Critical patent/AU2013344571A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2013344571A 2012-11-16 2013-11-15 Gonorrheal MtrE peptides and vaccines Abandoned AU2013344571A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261727451P 2012-11-16 2012-11-16
US61/727,451 2012-11-16
PCT/US2013/070310 WO2014078656A1 (en) 2012-11-16 2013-11-15 Gonorrheal mtre peptides and vaccines

Publications (1)

Publication Number Publication Date
AU2013344571A1 true AU2013344571A1 (en) 2015-06-04

Family

ID=50731717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013344571A Abandoned AU2013344571A1 (en) 2012-11-16 2013-11-15 Gonorrheal MtrE peptides and vaccines

Country Status (6)

Country Link
US (2) US9902756B2 (https=)
EP (1) EP2919806A4 (https=)
JP (1) JP2015536347A (https=)
AU (1) AU2013344571A1 (https=)
CA (1) CA2891552A1 (https=)
WO (1) WO2014078656A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10900043B2 (en) 2014-09-02 2021-01-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating bacterial disease
US10286016B2 (en) 2014-09-02 2019-05-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating gonorrhea
US12161707B2 (en) * 2016-09-02 2024-12-10 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
JP2023541671A (ja) * 2020-09-17 2023-10-03 プロシーナ バイオサイエンシーズ リミテッド シヌクレイノパチーの処置のためのアルファ－シヌクレインワクチン
GB202214756D0 (en) * 2022-10-07 2022-11-23 Univ Oxford Innovation Ltd Product

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1007730A4 (en) * 1996-08-30 2004-04-28 Invitrogen Corp METHODS OF IDENTIFYING AND ISOLATING SPECIFIC NUCLEOTIDE SEQUENCES IN cDNA AND GENOMIC DNA
EP2261352A3 (en) 1998-05-01 2012-01-04 Novartis Vaccines and Diagnostics, Inc. Neisseria meningitidis antigens and compositions
JP2001011096A (ja) * 1999-06-28 2001-01-16 Maruho Co Ltd 淋菌に対するヒト抗体
RU2281956C2 (ru) * 1999-10-29 2006-08-20 Чирон С.Р.Л. Антигенные пептиды neisseria
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
CN102869782B (zh) * 2010-03-01 2015-11-25 生化学工业株式会社 细菌产生软骨素的组合物和方法

Also Published As

Publication number Publication date
JP2015536347A (ja) 2015-12-21
US20150291666A1 (en) 2015-10-15
CA2891552A1 (en) 2014-05-22
US10414805B2 (en) 2019-09-17
US20190077837A1 (en) 2019-03-14
US9902756B2 (en) 2018-02-27
WO2014078656A1 (en) 2014-05-22
EP2919806A4 (en) 2016-06-22
EP2919806A1 (en) 2015-09-23

Similar Documents

Publication Publication Date Title
US10414805B2 (en) Gonorrheal MtrE peptides and vaccines
US7851609B2 (en) Chlamydia PMP proteins, gene sequences and uses thereof
HU225979B1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
JP2002503683A (ja) 結核の免疫療法および診断のための化合物および方法
JP3440221B2 (ja) アクチノバチルス・プレウロニウモニアからのタンパク質
US7314625B2 (en) Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences
WO2006125076A2 (en) Methods and compositions for immunizing against chlamydia infection
JP2023025066A (ja) ワクチン構築物およびブドウ球菌感染症に対するその使用
US7537772B1 (en) Chlamydia protein, gene sequence and the uses thereof
US9310381B2 (en) Engineered type IV pilin of Clostridium difficile
US7183402B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US20040138415A1 (en) Helicobacter proteins, nucleic acids and uses thereof
WO2000047744A1 (en) Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope
JP2005514052A (ja) Ｂ群連鎖球菌の新規の細胞表面プロテアーゼの使用
AU2002246667A1 (en) Helicobacter proteins, nucleic acids and uses thereof
WO1997039020A2 (en) Antigenic sequences of a sperm protein and immunocontraceptive methods
KR20060128894A (ko) 클라미디아 감염에 대한 면역화

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted